line), and urbanization (percent county pop. living in an urban area) categories to set national quintile cut points. SEER county incidence data were matched with their corresponding national education, poverty, and urbanization quintiles. The highest, middle, and lowest quintiles were compared over time using incidence rate ratio (IRR) and between quintiles by absolute disparity (AD; highest and lowest quintile range difference) and relative disparity (RD; highest and lowest quintile range ratio). Analysis was performed to 95% confidence intervals (CI) using the Tiwari et al. method.
INTRODUCTION AND OBJECTIVES: Implementation of evidenced-based patient-centered care is challenging in clinical settings. Success of such practice changes varies. The purpose of our study was to evaluate implementation strategies to deploy a shared decision aid for localized prostate cancer (LPC).
METHODS: The Personal Patient Profile-Prostate (P3P) is a web-based decision aid with demonstrated efficacy in reducing decisional conflict among men choosing a care plan for LPC. Implementation strategies were co-designed with leaders in six geographically-diverse urology clinics. As part of routine care, men were informed of P3P and offered access via a variety of methods. Physicians received 1-page summaries of P3P patient-generated reports of current symptoms and factors influencing the care decision. Focus groups including physicians, clinic staff and administrators were held at each site to solicit feedback after the implementation period. Access metrics were monitored for up to 6 months. General impressions, common barriers and promoters were identified and synthesized from the focus group data.
RESULTS: Two sites chose written information only to inform men of P3P, 1 site chose email only, 1 site chose email plus phone contact, 1 site chose MD instruction to use, followed by phone and email follow up and 1 site chose in clinic only. Barriers common to all settings included creating new workflows on top of heavy workloads, and staff and administrator misunderstanding of P3P context and resources. Staff inability to identify men with new LPC (vs follow up visits) hampered access. Promoters to successful implementation included an identified clinical lead, physician engagement and phone combined with email contact. Of all men with LPC seen in the clinics, 51% (range 15-98%) were informed of P3P. The highest rates of P3P access outside of clinic and prior to the consult visit (82, 73%) were observed when 2-3 modes of informing were implemented: physician, email and phone invitations. Clinic sites that chose to only provide written material with instruction to access P3P had the lowest access rates (range 0-14%). Physicians appraised the summaries as useful and helpful.
CONCLUSIONS: Despite challenges for clinic staff to add strategies to implement P3P to already heavy workloads, success was realized when physicians engaged and when staff provided follow up contacts to encourage P3P access. New practice changes to implement an evidence-based intervention require multi-modal strategies for early success. Future trials evaluating methods to reduce clinical workload may be of value.
Source of Funding: NIH 5R01NR009692

MP69-19 THE IMPACT OF RACE ON PERCEPTIONS OF ANXIETY AFTER LOCAL THERAPY FOR PROSTATE CANCER
Shilajit Kundu, Vincent Wong, Channa Amarasekera*, Kevin Lewis, Edward Schaeffer, Anthony Schaeffer, Joshua Meeks, David Victorson, James Burns, Sandra Gutierrez, Chicago, IL; Kevin McVary, Springfield, IL; Sarah Psutka, David Cella, Chicago, IL INTRODUCTION AND OBJECTIVES: Despite the potential side effects associated with treating prostate cancer, many men choose treatment over observation. The relative treatment benefits and harms to health related quality of life outcomes (HRQOL) remain poorly understood. In particular, there is a paucity of data detailing the differences in perceived treatment outcomes in African American (AA) and Hispanic men. We prospectively evaluated the functional and psychosocial effects of prostate cancer treatment in men and hypothesize that there may be differences in outcomes in Caucasian men vs. AA/Hispanic men.
METHODS: We enrolled 105 men with recently diagnosed prostate cancer at our institution in an internet-based study which used validated questionnaires to longitudinally assess HRQOL domains such as sexual and urinary function, bowel function, anxiety, and depression, at 1, 3, 6, and 12 months following treatment. Linear mixed models were used to examine changes in self-reported measures at enrollment (pretreatment) and at each post-treatment follow-up assessment. We focused our analysis on the 70 patients who chose radical prostatectomy or radiation therapy as treatment: 55 of these men were non-Hispanic white; 15 were AA or Hispanic.
RESULTS: Despite significant declines in functional outcomes such as erectile function (P<.001 for both groups), anxiety was significantly lowered post-treatment in both groups. Significant reductions in anxiety were noted for Caucasian men (3.9 points, P<0.001) and were even greater for AA/Hispanic men (5.7 points, P<.001). When controlling for differences in income, marital status, education, and improvements in urinary score, the impact on anxiety remained significant (P<0.05) at 3, 6, and 12 months. Based on previous analyses, these improvements are both statistically and clinically significant.
CONCLUSIONS: We found significant reductions in anxiety after local therapy. While these reductions were found in all men, AA and Hispanic men reported a greater reduction in anxiety compared to Caucasians. This suggests that AA/Hispanic men may have a different perspective regarding prostate cancer and treatment outcomes. Further work is necessary to elucidate this difference in perspective. Vol. 197, No. 4S, Supplement, Monday, May 15, 2017 THE JOURNAL OF UROLOGY â e933
